SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-071429
Filing Date
2021-12-28
Accepted
2021-12-28 19:37:58
Documents
1
Period of Report
2021-11-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4965
  Complete submission text file 0001209191-21-071429.txt   6625
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Issuer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21250 HAWTHORNE BOULEVARD SUITE 800 TORRANCE CA 90503
Business Address
Stark Charles William (Reporting) CIK: 0001901666 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35527 | Film No.: 211525962